Thursday, July 25, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

U.S. Government is Funding Gain-of-Function Research in China to Make Bird Flu More Infectious

by Carolyn Hendler, JD
gain-of-function research
The U.S government is again funding gain-of-function (GoF) research with Chinese scientists to make a dangerous virus even more potent. This time ...

FDA Adds Boxed Warning to Merck’s Asthma Drug Singulair About Suicide, Neuropsychiatric Side Effects

by Rishma Parpia
on a ledge
In 2008, the FDA issued a warning advising that it would investigate a possible risk of suicide associated with Merck & Co.'s ...

Pfizer Stock Posts Big Drop as Demand for COVID Shots and Paxlovid Dries Up

by Rishma Parpia
stock price down
The value of shares in Pfizer, Inc. stock has dropped by over eight percent in recent weeks, bringing it to the lowest ...

U.S. Taxpayer Funded Initiative Trains Dentists to Push HPV Vaccine

by Natasha Hobley
girl laying in dentist chair
In recent years, government health agencies, cancer societies, as well as the American Dental Association (ADA), have attempted to recruit dentists to ...

Blood Pressure Drug Recalled After Oxycodone Found on Production Line

by Amber Baker
betaxolol pills
Drug manufacturer KVK-Tech, Inc. has issued a voluntary recall of blood pressure drug betaxolol after oxycodone was discovered on the production line ...

FDA Panel Statements Prompt Pharmacies to Pull Popular Nasal Decongestants from Pharmacy Shelves

by Amber Baker
phenylephrine
Conventional over-the-counter cold meds promise cold symptom relief right on the front of their packaging, but U.S. Food and Drug Administration (FDA) ...

Nearly 50 Percent of Federal Panelists Making Dietary Recommendations Have Money Ties to Food Industry

by Natasha Hobley
money and food industry
About half of the members of a U.S. federal government panel that shapes dietary recommendations in the United States have significant financial ...

Pfizer Will Charge Patients $1,390 for COVID Anti-Viral Paxlovid

by Carolyn Hendler, JD
Paxlovid capsules
Pfizer, Inc. plans to charge consumers more than double the price charged to the U.S. government for its COVID-19 anti-viral drug nirmatrelvir-ritonavir, ...

In this section

Search in Archive